-
2021
December 2021Malignancy Risk Associated with the use of Mycophenolate Mofetil in Interstitial Lung Disease September 2021Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases August […]
-
2020
September 2020Frailty in patients with interstitial lung disease Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement August 2020Sputum quantitative cytometry in patients with […]
-
2019
November 2019Baseline characteristics and comorbidities in the Canadian Registry for Pulmonary Fibrosis Management of idiopathic pulmonary fibrosis: A survey of Canadian respirologists March 2019Screening for Myositis Antibodies in Idiopathic Interstitial […]
-
2018
November 2018Procedure volume and mortality after surgical lung biopsy in interstitial lung disease September 2018Comprehensive management of fibrotic interstitial lung disease: A Canadian Thoracic Society position statement June 2018Treatment of […]
-
2017
August 2017Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement
-
2016
July 2016Accuracy and Reliability of Internet Resources for Information on Idiopathic Pulmonary Fibrosis April 2016The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry